Send to

Choose Destination
Can Pharm J (Ott). 2018 Jun 3;151(5):305-314. doi: 10.1177/1715163518781175. eCollection 2018 Sep-Oct.

Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community.

Beahm NP1,2,3,4, Smyth DJ1,2,3,4, Tsuyuki RT1,2,3,4.

Author information

Faculties of Pharmacy and Pharmaceutical Sciences (Beahm), University of Alberta, Edmonton, Alberta.
Medicine & Dentistry (Tsuyuki), University of Alberta, Edmonton, Alberta.
Division of Infectious Diseases (Smyth), Department of Internal Medicine, Dalhousie University, Halifax, Nova Scotia.
Moncton Hospital (Smyth), Moncton, New Brunswick.



Pharmacists have the authorization to prescribe medications for the treatment of uncomplicated urinary tract infections (UTI) in some provinces. However, there are limited data on the outcomes of this care by pharmacists. Our objective was to evaluate the effectiveness, safety and patient satisfaction with pharmacist prescribing and care in patients with uncomplicated UTI.


We conducted a prospective registry trial in 39 community pharmacies in the Canadian province of New Brunswick. Adult patients were enrolled if they presented to the pharmacy with either symptoms of UTI with no current antibacterial treatment (Pharmacist-Initial Arm) or if they presented with a prescription for an antibacterial to treat UTI from another health care provider (Physician-Initial Arm). Pharmacists assessed patients and if they had complicating factors or red flags for systemic illness or pyelonephritis, they were excluded from the study. Pharmacists either prescribed antibacterial therapy, modified antibacterial therapy, provided education only or referred to physician, as appropriate. The primary outcome was clinical cure at 2 weeks and the secondary outcomes included adverse events and patient satisfaction.


A total of 750 patients were enrolled (87.4% in the Pharmacist-Initial Arm), average age was 40.9 (SD 16.0) years. Clinical cure was achieved in 88.9% of patients. Of those that did not have sustained symptom resolution, most (5.5% overall) had symptom recurrence after completion of therapy. Adverse events were reported by 7.2% of patients and 88.9% of those continued their medication. Most adverse events were gastrointestinal-related and transient. The patient satisfaction survey reflected very high levels of satisfaction for the care they received, as well as for trust and accessibility of the pharmacist.


Pharmacist management of uncomplicated UTI is effective, safe, and patient satisfaction appears very high.

Conflict of interest statement

Declaration of Conflicting Interests:The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center